Midwest Professional Planners, Ltd. Gilead Sciences, Inc. Transaction History

Midwest Professional Planners, Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $189,155 - $208,794	-3,026 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$61.87 - $69.38 $4,640 - $5,203	-75 Reduced 2.42%	3,026 $204,000
Q1 2019 May 08, 2019	BUY	$62.53 - $70.05 $193,905 - $217,225	3,101 New	3,101 $202,000
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $92,664 - $102,596	-1,300 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $583 - $681	-9 Reduced 0.69%	1,300 $92,000
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $30,082 - $36,674	413 Added 46.09%	1,309 $99,000
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $63,750 - $74,833	896	896 $64,000

1,926

992M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Midwest Professional Planners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Midwest Professional Planners, Ltd. with notifications on news.